Abstract We present a novel mass spectrometry-based high-throughput workflow and an open-source computational and data resource to reproducibly identify and quantify HLA-associated peptides. Collectively, the resources support the generation of HLA allele-specific peptide assay libraries consisting of consensus fragment ion spectra, and the analysis of quantitative digital maps of HLA peptidomes generated from a range of biological sources by SWATH mass spectrometry (MS). This study represents the first community-based effort to develop a robust platform for the reproducible and quantitative measurement of the entire repertoire of peptides presented by HLA molecules, an essential step towards the design of efficient immunotherapies.
Introduction
Next-generation immune-based therapies are expected to facilitate the eradication of intractable pathogens, cancer and autoimmune diseases (Koff et al., 2013) . T cells play a critical role in such therapies by their ability to detect the presence of disease-specific antigens/peptides presented by major histocompatibility complex (MHC) molecules (human leukocyte antigen [HLA] molecules in humans). Under steady-state or pathological conditions, thousands of HLA class I-associated peptides of 8-12 amino acids in length are displayed on the surface of virtually all nucleated cells for scrutiny by CD8+ T cells. HLA class II-associated peptides are 10-25 amino acids in length and are normally found on the surface of specialized antigen-presenting cells including macrophages and dendritic cells for presentation to CD4+ T cells. Collectively, HLA class I and class II peptides are referred to as the immunopeptidome, also known as HLA ligandome/peptidome (Caron et al., 2011; Kowalewski et al., 2014) . The composition of the immunopeptidome in the human population is complicated by the presence of more than 3000 HLA alleles, resulting in a high diversity of peptide repertoires characterized by the presence of HLA allele-specific binding motifs (Falk et al., 1991) . To be successful in designing efficient immunotherapies against autoimmunity, cancer and infectious diseases, it is becoming increasingly important to comprehensively map the complexity of the human immunopeptidome and to gain a more quantitative understanding of its dynamics in various disease states.
Mass spectrometry (MS) has evolved as the method of choice for the exploration of the human immunopeptidome (Hunt et al., 1992; Admon and Bassani-Sternberg, 2011; Granados et al., 2015) . The largest HLA peptidomes reported to date using MS contain more than 10,000 class I or class II peptides (Hassan et al., 2013; Bergseng et al., 2014; Bassani-Sternberg et al., 2015) . Estimates from various analytical and cell-based techniques also indicate that individual peptides are expressed on average at 50 copies per cell with extremes ranging from 1 to 10,000 copies per cell (Granados et al., 2015) . Until recently, the most common strategy for the analysis of immunopeptidomes by MS has focused on the isolation of HLA-bound peptides by immunoaffinity chromatography and the collection of fragment ion spectra of selected peptides through automated MS operated in data-dependent acquisition (DDA) mode. Although DDA is a powerful strategy for exploring the peptidomic content of various cell and tissue types, it is not a reliable platform for solving problems that require the comparison of comprehensive, quantitative, and reproducible data sets across many samples or conditions. In fact, analyses of complex/unfractionated digests of cell lysate using DDA have shown that as many as 84% of peptides may remain unselected for fragmentation even though they are clearly detectable by the mass spectrometer (Michalski et al., 2011) . Although the complexity of isolated HLA peptides is hardly comparable with that of cell lysate digests, as many as 20% of the selected HLA peptides can vary between replicate analyses of the same sample (Granados et al., 2014) (Figure 1-figure supplement 1A) . A second strategy, referred eLife digest The cells of the immune system protect us by recognizing telltale molecules produced by damaged and diseased cells, or by infection-causing microorganisms (which are also called pathogens). To help with this process, the cells in our bodies display small fragments of proteins (called peptides) on their surface that are then checked by the immune cells. Collectively, these peptides are referred to as the 'immunopeptidome', and deciphering the complexity of the human immunopeptidome is important for both basic research and medical science. Such an achievement would help to guide the development of next-generation vaccines and therapies against autoimmune disorders, infectious diseases and cancers.
In the past, immune peptides were mostly identified using a technique that is commonly called 'shotgun' mass spectrometry. However, this approach doesn't always provide reproducible results. In 2012, researchers reported the development of a new approach-which they called 'SWATH' mass spectrometry-that could yield more reproducible data. Now, Caron et al.-including many of the researchers involved in the 2012 study-have developed a large collection of standardized tests that use SWATH mass spectrometry to analyze the human immunopeptidome. The workflow and the computational and data resources developed as part of this international effort are the first steps toward highly reproducible and measurable analyses of the immunopeptidome across many samples. Moreover, the large repository of assays generated by the project has been made public and will serve a large community of researchers, which should enable better collaborations.
In the future, SWATH mass spectrometry could be used as a robust technology for the reproducible detection and measurement of pathogen-specific or cancer-specific immune peptides. This could greatly help in the design of personalized immune-based therapies.
to as selected/multiple reaction monitoring (S/MRM), is a targeting MS technique capable of generating highly reproducible, quantitatively accurate and sensitive datasets (Picotti and Aebersold, 2012) . S/MRM is, however, limited by its capacity to detect only tens to hundreds of peptides per sample injection and thus is not ideally suited to comprehensively quantify HLA peptidomes. To overcome this limitation, we recently introduced SWATH-MS, a new mass spectrometric technique that combines data-independent acquisition (DIA) with a targeted data extraction strategy (Gillet et al., 2012; Röst et al., 2014) . In DIA mode, all peptides in a sample are fragmented and the corresponding fragment ion spectra are acquired, resulting in a digital recording of the peptide sample. DIA is an unbiased MS technique and therefore represents a suitable strategy for efficiently generating consistent, reproducible and quantitatively accurate measurements of peptides across multiple samples (Gillet et al., 2012; Collins et al., 2013; Rosenberger et al., 2014; Röst et al., 2014; Guo et al., 2015; Liu et al., 2015; Schubert et al., 2015a) .
To extract quantitative information from digital SWATH-MS data, high-quality assay libraries are required. Such libraries contain retention-time and fragmentation information of the peptides to be targeted. Assay libraries are generated from native and/or synthetic peptides using a SWATH compatible mass spectrometer operated in DDA mode. To date, several generic SWATH assay libraries were generated for the analysis of proteomes in various species. These include Mycobacterium tuberculosis (Schubert et al., 2015a) , Saccharomyces cerevisiae (Selevsek et al., 2015) , and Homo sapiens . Assay libraries were successfully employed to measure a limited number of MHC class I peptides by S/MRM in various contexts-that is, viral infection (Croft et al., 2013) , autoimmunity (Schittenhelm et al., 2014a) and cancer (Gubin et al., 2014)-but have never been created for robust quantitative and high-throughput measurement of HLA-associated peptides by SWATH-MS.
For the SWATH-MS technology to meet its potential to support rapid advances in the design of next-generation vaccines and immunotherapies, comprehensive HLA peptide assay libraries have to be created and made readily available to basic and translational scientists. Generating such assay libraries could ultimately enable the fast and reproducible quantification of the entire repertoire of HLA peptides across many samples. Towards this end, we developed a workflow to (1) generate a pilot repository of HLA allele-specific peptide spectral and assay libraries, and to (2) analyze SWATH-MS HLA peptidomic data acquired from multiple international laboratories (Figure 1) . In this study, libraries were created from natural and/or synthetic HLA class I and II peptides whereas analysis of SWATH-MS HLA peptidomic data focused mainly on naturally presented class I peptides.
Results and discussion
Large-scale DDA-based identification of immunoaffinity purified HLA class I peptides is supported by several software tools (e.g., MaxQuant, Perseus or X-PRESIDENT) and results in thousands of unclassified peptides of various lengths. Since large HLA peptidomic datasets are generated at an increasing pace, additional computational frameworks facilitating the HLA annotation and storage of such datasets need to be developed. Here, we first created a computational workflow to support the identification, classification/annotation, visualization and storage of HLA peptidomic data in an alleledependent manner. The software tools described in the section below enable (1) systematic annotation of peptides to their respective HLA allele, (2) visualization of HLA peptidomic datasets, and (3) generation of HLA class I allele-specific peptide spectral libraries, which can be converted into high quality assay libraries for the processing of SWATH-data ( To test our workflow, the generated data and computational resources, we first assessed the feasibility of generating HLA class I allele-specific peptide spectral libraries from a panel of fourteen PBMC samples (PBMC #1-14) expressing different combinations of HLA class I alleles. HLA class Ibound peptides were isolated from HLA-typed PBMC's by immunoaffinity chromatography and analyzed by DDA on an Orbitrap-XL mass spectrometer ( Figure 2 and Figure 2 -source data 1). Peptides were identified using multiple open-source database search engines. The search identifications were combined and statistically scored using PeptideProphet and iProphet within the Trans-Proteomic Pipeline (TPP) as shown previously (Figure 1) (Shteynberg et al., 2011 (Shteynberg et al., , 2013 . We next annotated the identified peptides to their respective HLA allele. Previously, HLA binding prediction algorithms such as SYFPETHI, NetMHC and SMM were used for manual or semi-automated annotation of HLA peptides (Fortier et al., 2008; Berlin et al., 2014; Granados et al., 2014) . Here, we designed a fully automated annotation strategy integrating the stand-alone software package of the HLA binding prediction algorithm NetMHC 3.4 with a set of in-house software tools (Figure 2-figure supplement 1) . The in-house software tools enable an automated, consistent and effective annotation of the majority of the identified peptides to their respective HLA allele (Supplementary file 1). Briefly, each identified peptide was given a predicted HLA binding affinity (IC 50 ) for each of the HLA alleles expressed in the corresponding healthy donor. An HLA annotation score was then computed for each individual peptide by dividing its second best IC 50 value (i.e., the second best predicted allele) by its best IC 50 value (i.e., the best predicted allele). The higher this annotation score was, the higher the probability was for the peptide to be correctly annotated to a specific HLA allele. As an example, in PMBC#2, an annotation score of 77 was computed for the KLEEQARAK peptide by dividing 21,400 nM (second best IC 50 value predicted for HLA-B39) by 278 nM (best IC 50 value predicted for HLA-A03) (Figure 2-figure supplement 1A) . Peptides with an HLA annotation score ≥3 (selected cutoff value; see 'Materials and methods' and Supplementary file 1) were systematically annotated to the allele predicted to bind best (e.g., HLA-A03 for the KLEEQARAK peptide). Using this scoring strategy, ∼80% of all identified 8-12-mers were annotated to a specific HLA-A or -B allele (Figure 2-source data 2). HLA-A and -B alleles were prioritized due to the high reliability of the NetMHC 3.4 predictor for a broad diversity of HLA-A and -B alleles as well as for their high expression levels Bassani-Sternberg et al., 2015; Trolle et al., 2015) . Peptides with an annotation score below 3 were considered as non-annotated in this study and were discarded for the process of building the HLA allele-specific peptide spectral libraries. Tables including scored peptides were then used to generate heat maps and visualize HLA-A and -B peptidomes of PBMC's as described ( Figure 2B and Supplementary file 1). Of note, allele-supertype peptides (i.e., peptides predicted to strongly bind more than one allele with an IC 50 below 500 nM) were curated in the output files but were not visualized on the heat maps in this study. A corrected false discovery rate (cFDR) was estimated for each PBMC sample following removal of all nonannotated contaminant peptides ( the HLA class I allele-specific peptide spectral libraries ('Materials and methods'). The same procedure was applied to peptides identified from JY EBV+ and C1R cells. Notably, endogenous HLA-C04 peptides were recently shown to be significantly expressed on the surface of C1R cells (Schittenhelm et al., 2014b) and were therefore considered in this study. In total, 3528 HLA-A peptides, 4208 HLA-B peptides and 205 HLA-C04 peptides were recorded in the spectral libraries, which were then stored in the public PeptideAtlas database (Figure 2-source data 4) . In summary, we generated a computational workflow to effectively annotate and visualize HLA peptidomic data, which were finally converted and stored into HLA allele-specific peptide spectral libraries consisting of consensus fragment ion spectra. This strategy could be further refined to collect, store and share HLA peptidomic information obtained from various cell lines and from larger cohorts of donors. Importantly, this computational approach can be broadly applied to generate SWATH-compatible assay libraries as described below.
Libraries of consensus fragment ion spectra can be converted into high quality assays for highthroughput targeted analysis of SWATH-MS data, an emerging approach for reproducible, consistent and accurate quantitative measurements of peptides (Gillet et al., 2012; Collins et al., 2013; Rosenberger et al., 2014; Röst et al., 2014; Guo et al., 2015; Liu et al., 2015; Selevsek et al., 2015; Schubert et al., 2015a) . Here, we aimed at initiating a worldwide community-based effort to generate pilot HLA allele-specific peptide assay libraries that could be further used for the analysis of SWATH-MS HLA peptidomic data. Naturally presented and/or synthetic HLA class I and class II peptides were provided from six independent laboratories and were analyzed using four distinct TripleTOF 5600 MS instruments operated in DDA acquisition mode in four different international institutions. Naturally presented HLA class I peptides from JY EBV+ (HLA-A02 and -B07), PBMC (HLA-A03, -A26, -B51 and -B57), and Jurkat (HLA-A03, -B07 and -B35) cells were isolated by immunoaffinity chromatography (Figure 2-source data 1) . Natural class I peptides from three C1R cell lines-stably expressing HLA-C04 as well as HLA-B27, -B39 or -B40 molecules-were also isolated using the same procedure. Synthetic EBV-derived peptides known to bind HLA-A02 or -B07 were also used to build the libraries (Figure 2 -source data 2). All laboratories used the spiked-in landmark iRT peptides for retention time normalization (Escher et al., 2012) . The DDA data generated by the different groups were shared and pipelined through the computational workflow described above, resulting in the identification of 7668 (peptide-level FDR 1%; average cFDR 0.5%) or 11,275 (peptide-level FDR 5%; average cFDR 2.5%) distinct HLA class I peptides distributed across eleven different HLA class I alleles (Figure 2-figure supplement 2B and Figure 2 -source data 3). To properly assess the efficiency of generating HLA peptide assay libraries from synthetic peptides, a large collection of 20,176 synthetic HLA class II peptides was analyzed by DDA using different mass spectrometers and fragmentation methods (Figure 2-figure supplement 3 and Figure 2 -source data 2). Our results show that a total of 15,875 peptides (∼79%) were identified (Figure 2-source data 2) . A large collection of synthetic HLA class I peptides was not available but could be used in the future to extend the contents of the present class I libraries derived from native peptides. All identified peptides were used to build the HLA allele-specific peptide assay libraries ('Materials and methods'). To date, the pilot libraries contain a total of 223,735 transitions for 26,857 unique peptides and were stored by class and allele in the SWATHAtlas database (Figure 2 -source data 5 and http://www.swathatlas.org). By using the automated HLA peptide annotation method described above, we observed that similar binding affinities were predicted for HLA class I peptides identified at peptide-level FDR 1% and peptide-level FDR 5% (Figure 2-figure supplement 4 and Figure 2 -figure supplement 5), suggesting that a large fraction of true positives were excluded at peptide-level FDR 1%. Our data also show that 95% of the annotated class I peptides in this study were predicted to bind their respective HLA molecules with an IC 50 ranging from 72 nM (for HLA-A01) to 5682 nM (for HLA-B51) at peptide-level FDR 1% (Figure 2-figure supplement 4) . Similar results were obtained at peptide-level FDR 5% (Figure 2-figure supplement 5) . This result supports a recent study indicating that HLA class I alleles are associated with peptide-binding repertoires of different affinity (Paul et al., 2013) . Altogether, we demonstrated the feasibility of collecting DDA data from multiple international laboratories to generate standardized HLA allele-specific peptide assay libraries. We anticipate this global effort as a first step towards the development of a standardized Pan-human HLA peptide assay library, which could be used to rapidly and reproducibly quantify the entire repertoire of peptides presented by HLA molecules using SWATH-MS. SWATH-MS is emerging as a robust next-generation proteomics technique for efficiently generating reproducible, consistent and quantitatively accurate measurements of peptides across multiple samples (Gillet et al., 2012; Collins et al., 2013; Rosenberger et al., 2014; Röst et al., 2014; Guo et al., 2015; Liu et al., 2015; Selevsek et al., 2015; Schubert et al., 2015a) . To promote the worldwide development of SWATH-based MS platforms towards robust quantitative measurements of HLA peptidomes, we assessed whether the HLA allele-specific assay libraries described above could be used to extract quantitative information from digital SWATH maps acquired by different laboratories. Importantly, four independent laboratories generated their own digital SWATH maps using TripleTOF 5600 MS operated in DIA acquisition mode. Naturally presented HLA class I peptides were isolated from the cell types mentioned above (i.e., JY EBV+ , Jurkat, PBMC and C1R). Precursors in the range of 400-1200 Th were divided into 32 SWATH windows of 25 Da (Gillet et al., 2012) . All ionized peptide precursors in this mass range were fragmented, generating comprehensive and quantitative digital fragment ion maps. The HLA peptidome of JY EBV+ cells was analyzed using the OpenSWATH ) software tool and a combined assay library containing 22,206 transitions for 1507 HLA-A02 and 2194 HLA-B07 peptides-the two dominant HLA alleles expressed on these cells. At an estimated peptide-level FDR of 1% (m-score < 0.01), a total of 3150 unique HLA class I peptides were identified from the digital SWATH map ( Figure 3A Figure 3-source data 1) . Notably, assays generated from the synthetic EBV-related class I peptides enabled the identification of one EBVderived HLA-A02 peptide ( Figure 3C ), thereby demonstrating that building high-quality assay libraries from synthetic class I peptides of pathogen origin could be useful for the identification of nonself HLA-bound peptides by SWATH-MS. To analyze self-HLA peptides isolated from PBMC (HLA-A03, -A26, -B51 and -B57), Jurkat (HLA-A03, B07 and -B35), C1R-B27 (HLA-B27) and C1R-B40 (HLA-B40) cells, the matching HLA class I allele-specific peptide assay libraries were combined accordingly using SpectraST and then processed in the OpenSWATH software. High-throughput targeted analysis from these four additional peptidomic datasets indicated that ∼81% of HLA class I peptides present in an assay library could be extracted from a quantitative digital SWATH map in a cell type-independent manner (peptide-level FDR 1%) (Figure 3-figure supplement 1C, Figure 3 -figure supplements 2-6 and Figure 3 -source data 1). We next optimized the SWATH acquisition conditions according to the size distribution of HLA class I peptides. Most class I peptide precursors (∼98%) fall within the range of 400-700 Th and were divided in 30 SWATH windows of 10 Da width each. Using SWATH data generated from JY EBV+ cells, we found that narrowing the size of the windows by 2.5-fold resulted in a ∼13% foldincrease in the identification of class I peptides (Figure 3-figure supplement 1A) . The R 2 value for SWATH-MS quantification was 0.979 from two technical replicates ( Figure 3D ). In accordance with previous studies, we also observed that the dynamic range of peptides quantified in different cell types using SWATH-MS, based on their signal intensity, was about 3-4 orders of magnitude ( Figure 3E ) (Hassan et al., 2013; Bassani-Sternberg et al., 2015) . Altogether, we demonstrate the feasibility of an international effort to build standardized HLA allele-specific peptide assay libraries, which were used to extract quantitative information from digital SWATH maps acquired in different sites. We therefore provide a proof of concept that acquisition of SWATH-MS HLA peptidomic data may enable robust analysis of the human immunopeptidome on a global scale.
To further establish the robustness of SWATH-MS for the measurement of HLA-associated peptides, we tested whether the JY EBV+ HLA peptidome could be reproducibly detected across multiple MS injections. For this purpose, we prepared a sample of class I peptides by immunoaffinity purification from JY EBV+ cells and we acquired three datasets in SWATH mode. The datasets were analyzed using OpenSWATH and a combined HLA-A02 and -B07 peptide assay library as described above. At an estimated peptide-level FDR of 1%, a total of 2933 unique HLA class I peptides were identified by SWATH-MS and 2832 peptides (97%) were found in all the SWATH analyses ( Figure 1-figure supplement 1B, Figure 1 -source data 1). We then conducted a comparative analysis by acquiring three additional datasets in DDA mode from the same sample of class I peptides using the same chromatographic conditions. In total, 3153 HLA-A and -B peptides were identified at 1% peptide-level FDR and 1261 peptides (40%) were found in all the DDA analyses (Figure 1-figure  supplement 1A , Figure 1-source data 1) . Thus, the SWATH method clearly outperformed the DDA approach for the reproducible identification of JY EBV+ HLA class I peptides across several technical replicates. Overall, our results indicate that SWATH-MS has the capability of detecting large numbers of HLA peptides across multiple injections at a high degree of reproducibility. By providing a community resource for the continuous expansion of the library contents and by improving the performance of the OpenSWATH software, it can be expected that additional HLA peptides-including cryptic and mutant peptides-will be reproducibly identified and quantified from the same digital SWATH maps in the future.
The life sciences community greatly benefits from robust technologies such as microarrays and RNA-seq. Similarly, robust generation and analysis of quantitative digital maps of HLA peptidomes is expected to have important implications in basic and translational research as these will allow research groups to accurately investigate the dynamics of immunopeptidomes in various immune-related diseases such as autoimmunity, infectious diseases and cancers. For instance, reproducible digital mapping of tumor-specific mutant HLA peptides during cancer progression will facilitate stratification of patients who might best benefit from innovative immunotherapeutic interventions (Gubin et al., 2014; Snyder et al., 2014; Schumacher et al., 2015) . The workflow and the computational and data resources presented in this community-based study is a first step towards highly reproducible and quantitative MS-based measurements of HLA peptidomes across many samples and could therefore be greatly beneficial in the design of personalized immune-based therapies. Moreover, the storage of HLA peptide spectral and assay libraries by class and allele in the SWATHAtlas database provides an initial framework to collect, organize and share HLA peptidomic data, thereby supporting the recently proposed Human Immunopeptidome and Vaccines Projects (Admon and Bassani-Sternberg, 2011; Koff et al., 2014) .
Materials and methods

Blood samples, cell lines and synthetic peptides
PBMCs from healthy donors were isolated by density gradient centrifugation. Informed consent was obtained in accordance with the Declaration of Helsinki protocol. HLA typing was carried out by the Department of Hematology and Oncology, Tübingen, Germany. PBMCs were stored at −80˚C until further use. JY EBV+ , Jurkat and C1R cells were cultured in RPMI supplemented with 10% fetal bovine serum, 50 IU/ml penicillin, and 50ug/ml streptomycin (Invitrogen, Life Technologies Europe BV, Zug, Switzerland). C1R cells were stably transfected with -B2705, -B3901 and -B4002 constructs, as described previously (Marcilla et al., 2014; Schittenhelm et al., 2014a) . The EBV peptide was synthesized by Thermo Fischer Scientific (Ulm, Germany). The collection of 20,176 MTB peptides was synthesized by Mimotopes (Victoria, Australia) as described (Lindestam Arlehamn et al., 2013) . Isolation of HLA peptides HLA class I peptide complexes were isolated by standard immunoaffinity purification as described previously using the pan-HLA class I-specific mAb W6/32 (Hunt et al., 1992; Croft et al., 2013; Kowalewski and Stevanovic, 2013; Marcilla et al., 2014) .
RT normalization peptides
For the RT normalization and analysis, the peptides from the iRT Kit (Biognosys AG, Schlieren, Switzerland) were added to samples (see Figure 2 -source data 1) prior to MS injection according to vendor instructions (Escher et al., 2012) .
DDA mass spectrometry AB SCIEX TripleTOF 5600 + Both naturally presented and synthetic HLA peptides were analyzed using a TripleTOF system (see Figure 2 -source data 1) as described before (Gillet et al., 2012; Röst et al., 2014) . Samples were analyzed on an Eksigent nanoLC (AS-2/1Dplus or AS-2/2Dplus) system coupled with a SWATH-MSenabled AB SCIEX TripleTOF 5600 + System. The HPLC solvent system consisted of buffer A (2% acetonitrile and 0.1% formic acid in water) and buffer B (2% water with 0.1% formic acid in acetonitrile). The samples were separated in a 75 μm-diameter PicoTip emitter (New Objective, Woburn, MA) packed with 20 cm of Magic 3 μm, 200Å C18 AQ material (Bischoff Chromatography, Leonberg, Germany). The loaded material was eluted from the column at a flow rate of 300 nl/min with the following gradient: linear 2-35% B over 120 min, linear 35-90% B for 1 min, isocratic 90% B for 4 min, linear 90-2% B for 1 min and isocratic 2% solvent B for 9 min. The mass spectrometer was operated in DDA top20 mode, with 500 and 150 ms acquisition time for the MS1 and MS2 scans respectively, and 20 s dynamic exclusion. Rolling collision energy with a collision energy spread of 15 eV was used for fragmentation.
Thermo scientific orbitrap ELITE
Mtb synthetic peptides were analyzed on an Eksigent LC system coupled to an LTQ-Orbitrap ELITE mass spectrometer. Peptides were separated on a custom C18 reversed phase column (150 mm i.d. × 100 mm, Jupiter Proteo 4 mm, Phenomenex) using a flow rate of 600 nl min −1 and a linear gradient of 3-60% aqueous ACN (0.2% formic acid) in 120 min. Full mass spectra were acquired with the Orbitrap analyser operated at a resolving power of 30,000 (at m/z 400). Mass calibration used an internal lock mass (protonated (Si(CH3)2O))6; m/z 445.120029) and mass accuracy of peptide measurements was within 5 p.p.m. MS/MS spectra were acquired in CID and HCD mode with a normalized collision energy of 35%. Up to ten precursor ions were accumulated to a target value of 50,000 with a maximum injection time of 300 ms and fragment ions were transferred to the Orbitrap analyser operating at a resolution of 15,000 at m/z 400.
Thermo scientific orbitrap XL
Naturally presented HLA class I peptides from several PBMC samples (see Figure 2 -source data 1) were also analyzed by reversed-phase liquid chromatography (nano-UHPLC, UltiMate 3000 RSLCnano; Thermo Fisher, Waltham, MA, USA) coupled with an LTQ Orbitrap XL hybrid mass spectrometer. Samples were analyzed in five technical replicates. Sample volumes of 5 μl (sample shares of 20%) were injected onto a 75 μm × 2 cm trapping column (Acclaim PepMap RSLC; Thermo Fisher) at 4 μl/min for 5.75 min. Peptide separation was subsequently performed at 50˚C and a flow rate of 175 nl/min on a 50 μm × 50 cm separation column (Acclaim PepMap RSLC; Thermo Fisher) applying a gradient ranging from 2.4 to 32.0% of acetonitrile over the course of 140 min. Eluting peptides were ionized by nanospray ionization and analyzed in the mass spectrometer implementing a top five CID method generating fragment spectra for the five most abundant precursor ions in the survey scans. Resolution was set to 60,000. For HLA class I ligands, the mass range was limited to 400-650 m/z with charge states 2 and 3 permitted for fragmentation.
Database search engines and statistical validation
All raw instrument data were centroided and processed as described previously (Collins et al., 2013; Rosenberger et al., 2014) . The datasets were searched individually using X!tandem (Craig et al., 2004) , MS-GF+ (Kim and Pevzner, 2014) and Comet (Eng et al., 2012 ) against the full non-redundant, canonical human genome as annotated by the UniProtKB/Swiss-Prot (2014_02) with
DIA mass spectrometry (SWATH-MS)
For SWATH-MS data acquisition, the same mass spectrometer and LC-MS/MS setup was operated essentially as described before (Collins et al., 2013; Rosenberger et al., 2014 ) using 32 windows of 25 Da effective isolation width (with an additional 1 Da overlap on the left side of the window) and with a dwell time of 100 ms to cover the mass range of 400-1200 m/z in 3.3 s. Before each cycle, an MS1 scan was acquired, and then the MS2 scan cycle started (400-425 m/z precursor isolation window for the first scan, 424-450 m/z for the second... 1,174-1200 m/z for the last scan). The collision energy for each window was set using the collision energy of a 2+ ion centered in the middle of the window with a spread of 15 eV. Four independent international laboratories acquired their own SWATH maps using the settings described above: (1) Antony Purcell, Monash University; (2) Nicola Ternette, University of Oxford; (3) Miguel Marcilla, Spanish National Biotechnology Center; (4) Ruedi Aebersold, ETH-Zurich.
SWATH-MS data analysis
The iPortal workflow was used for data analyses (Kunszt et al., 2014) . The OpenSWATH analysis workflow (OpenSWATHWorkflow) (http://www.openswath.org) was implemented in the iPortal workflow. The parameters were selected analogously to the ones described before : min_rsq: 0.95, min_coverage: 0.6, min_upper_edge_dist: 1, mz_extraction_window: 0.05, rt_extraction_window: 600, extra_rt_extraction_window: 100. pyprophet (https://pypi.python.org/pypi/pyprophet) was run on the OpenSwathWorkflow output adjusted to contain the previously described scores (xx_swath_prelim_score, bseries_score, elution_model_fit_score, intensity_score, isotope_correlation_score, isotope_overlap_score, library_corr, library_rmsd, log_sn_score, massdev_score, massdev_score_weighted, norm_rt_score, xcorr_coelution, xcorr_coelution_weighted, xcorr_shape, xcorr_shape_weighted. yseries_score) . Assay libraries were loaded into Skyline and SWATH traces were analyzed as described previously (Schubert et al., 2015b) . Advanced protocols for analysis of SWATH/DIA data can be downloaded from the website: http://skyline.maccosslab.org. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. 
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The following datasets were generated: 
